Vivitrol naltrexone regulatory update

Alkermes said FDA tentatively scheduled a meeting of the Psychopharmacologic Drugs Advisory Committee on Sept. 16 to discuss an sNDA for Vivitrol naltrexone to treat opioid dependence. The PDUFA date ...